152 related articles for article (PubMed ID: 37602452)
21. LncRNA
Li F; Hu Q; Pang Z; Xu X
Cancer Biother Radiopharm; 2020 Feb; 35(1):72-76. PubMed ID: 31910343
[No Abstract] [Full Text] [Related]
22. LncRNA MAGI2-AS3 suppresses the proliferation and invasion of non-small cell lung carcinoma through miRNA-23a-3p/PTEN axis.
Hao XZ; Yang K
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7399-7407. PubMed ID: 31539127
[TBL] [Abstract][Full Text] [Related]
23. Long noncoding MAGI2-AS3 promotes colorectal cancer progression through regulating miR-3163/TMEM106B axis.
Ren H; Li Z; Tang Z; Li J; Lang X
J Cell Physiol; 2020 May; 235(5):4824-4833. PubMed ID: 31709544
[TBL] [Abstract][Full Text] [Related]
24. Long non-coding RNA MAGI2-AS3 inhibits breast cancer cell migration and invasion via sponging microRNA-374a.
Du S; Hu W; Zhao Y; Zhou H; Wen W; Xu M; Zhao P; Liu K
Cancer Biomark; 2019; 24(3):269-277. PubMed ID: 30883342
[TBL] [Abstract][Full Text] [Related]
25. LncRNA MAGI2-AS3-Encoded Polypeptide Restrains the Proliferation and Migration of Breast Cancer Cells.
Zhang Z; Yi Y; Wang Z; Zhang H; Zhao Y; He R; Luo Y; Cui Z
Mol Biotechnol; 2024 Jun; 66(6):1409-1423. PubMed ID: 37358745
[TBL] [Abstract][Full Text] [Related]
26. Long non-coding RNA HCP5 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-140-5p/IGF1R pathway.
Zhang YJ; Lu C
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):2965-2975. PubMed ID: 32271414
[TBL] [Abstract][Full Text] [Related]
27. LncRNA MAGI2-AS3 Affects Cell Invasion and Migration of Cervical Squamous Cell Carcinoma (CSCC) via Sponging miRNA-233/EPB41L3 Axis.
Hou A; Zhang Y; Fan Y; Zheng Y; Zhou X; Liu H
Cancer Manag Res; 2020; 12():4209-4216. PubMed ID: 32581592
[TBL] [Abstract][Full Text] [Related]
28. Hypermethylation-Mediated lncRNA MAGI2-AS3 Downregulation Facilitates Malignant Progression of Laryngeal Squamous Cell Carcinoma via Interacting With SPT6.
Wang J; Yang C; Cao H; Yang J; Meng W; Yu M; Yu L; Wang B
Cell Transplant; 2023; 32():9636897231154574. PubMed ID: 36852700
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA MiR-490-5p suppresses pancreatic cancer through regulating epithelial-mesenchymal transition via targeting MAGI2 antisense RNA 3.
Xu Z; Chen Z; Peng M; Zhang Z; Luo W; Shi R; Wang L; Hong Y
Bioengineered; 2022 Feb; 13(2):2673-2685. PubMed ID: 35043728
[TBL] [Abstract][Full Text] [Related]
30. CircPVT1 promotes progression in clear cell renal cell carcinoma by sponging miR-145-5p and regulating TBX15 expression.
Zheng Z; Chen Z; Zhong Q; Zhu D; Xie Y; Shangguan W; Xie W
Cancer Sci; 2021 Apr; 112(4):1443-1456. PubMed ID: 33453148
[TBL] [Abstract][Full Text] [Related]
31. Roles of lncRNA MAGI2-AS3 in human cancers.
Kai-Xin L; Cheng C; Rui L; Zheng-Wei S; Wen-Wen T; Peng X
Biomed Pharmacother; 2021 Sep; 141():111812. PubMed ID: 34126355
[TBL] [Abstract][Full Text] [Related]
32. circCHST15 is a novel prognostic biomarker that promotes clear cell renal cell carcinoma cell proliferation and metastasis through the miR-125a-5p/EIF4EBP1 axis.
Gui CP; Liao B; Luo CG; Chen YH; Tan L; Tang YM; Li JY; Hou Y; Song HD; Lin HS; Xu QH; Yao GS; Yao HH; Xi-Liu ; Luo JH; Cao JZ; Wei JH
Mol Cancer; 2021 Dec; 20(1):169. PubMed ID: 34922539
[TBL] [Abstract][Full Text] [Related]
33. LncRNA ITGB2-AS1 promotes the progression of clear cell renal cell carcinoma by modulating miR-328-5p/HMGA1 axis.
Zhang W; Lu Y; Shi H; Li X; Zhang Z; Deng X; Yang Y; Wan B
Hum Cell; 2021 Sep; 34(5):1545-1557. PubMed ID: 34170494
[TBL] [Abstract][Full Text] [Related]
34. [MiR-744-5p inhibits the proliferation, invasion, and migration of clear-cell renal cell carcinoma cells by targeting CCND1].
Lei K; Xie W; Sun T; Liu Y; Wang X
Nan Fang Yi Ke Da Xue Xue Bao; 2022 May; 42(5):712-717. PubMed ID: 35673915
[TBL] [Abstract][Full Text] [Related]
35. Blocking lncRNA MIR155HG/miR-155-5p/-3p inhibits proliferation, invasion and migration of clear cell renal cell carcinoma.
Tao M; Zhou Y; Jin Y; Pu J
Pathol Res Pract; 2020 Feb; 216(2):152803. PubMed ID: 31889587
[TBL] [Abstract][Full Text] [Related]
36. Long noncoding RNA MAGI2-AS3 inhibits bladder cancer progression through MAGI2/PTEN/epithelial-mesenchymal transition (EMT) axis.
Shen D; Xu J; Cao X; Cao X; Tan H; Deng H
Cancer Biomark; 2021; 30(2):155-165. PubMed ID: 33104021
[TBL] [Abstract][Full Text] [Related]
37. Novel insights for lncRNA MAGI2-AS3 in solid tumors.
Xue C; Li G; Lu J; Luo J; Jia J
Biomed Pharmacother; 2021 May; 137():111429. PubMed ID: 33761624
[TBL] [Abstract][Full Text] [Related]
38. Long non-coding RNA MAGI2
Wei X; Hou Y; Zhang Y; Zhang H; Sun Z; Meng X; Wang Z
J Cancer; 2022; 13(1):343-353. PubMed ID: 34976194
[TBL] [Abstract][Full Text] [Related]
39. MiR-212-5p inhibits the malignant behavior of clear cell renal cell carcinoma cells by targeting TBX15.
Deng JH; Zheng GY; Li HZ; Ji ZG
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10699-10707. PubMed ID: 31858538
[TBL] [Abstract][Full Text] [Related]
40. Long noncoding RNA HOXC-AS3 enhances the progression of cervical cancer via activating ErbB signaling pathway.
Zhao R; Song J; Jin Y; Liu Y
J Mol Histol; 2021 Oct; 52(5):991-1006. PubMed ID: 34387789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]